Increased IGFBP-3 expression was observed in kidney renal clear cell carcinoma (log2 fold change +3.44), lung squamous cell carcinoma (log2 fold change +2.26), lung adenocarcinoma (log2 fold change +1.94), head and neck squamous cell carcinoma (log2 fold change +1.32), stomach adenocarcinoma (log2 fold change +1.18), thyroid carcinoma (log2 fold change +1.11), bladder urothelial carcinoma (log2 fold change +1.05), colon adenocarcinoma (log2 fold change +0.65), and kidney renal papillary cell carcinoma (log2 fold change +0.34). This evidence concerns the gene IGFBP3 and bladder transitional cell carcinoma.